Thrombus Management in ACS: Key Results of The CHEETAH Study

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

Thrombus Management in ACS: Key Results of The CHEETAH Study

By Penumbra, Inc. FEATURING Santhosh Jay Mathews

0 views

February 16, 2022

Presented at TCT 2021, the CHEETAH trial marks the first study looking at continuous power aspiration for high thrombus burden in the coronaries. National Principal investigator Dr. Jay Mathews from Manatee Memorial shares the key results from the CHEETAH Trial and discusses the clinical impact of this technology.

Comments 0